🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Additionally, a robust trade exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Sellers market the drug there before directing buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

However, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could result in users administering products of unknown origin.

Several professionals said the demand for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the British medical regulations.

Several content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and customer regulations, risking fines, legal action or imprisonment.

Service Response and Content Removal

According to the social media company, the service has removed problematic material and prohibited associated keywords and query recommendations. The company stated it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also found groups with up to nine thousand members marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, positive reviews and detailed guides for preparing or administering at residence.

After moments of entering one group, a vendor shared WhatsApp details, where most transactions take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Item Details and Pricing

Inside these groups, posts display black plastic packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how much time a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.

Service Moderation and Security Actions

A representative for the messaging service stated it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they can’t verify. Although the research behind retatrutide is sound, these digital versions may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already seen patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a company experimental substance not yet approved … may expose patients to possibly serious health risks”.